Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy

Aims  The aim of the present study was to determine the diagnostic accuracy of the Neuropad sudomotor test for diabetic cardiovascular autonomic neuropathy (CAN) and diabetic polyneuropathy (DPN), the latter assessed using a multi‐level diagnostic approach. Methods  In 51 diabetic patients, CAN, sym...

Full description

Saved in:
Bibliographic Details
Published inDiabetic medicine Vol. 26; no. 7; pp. 686 - 692
Main Authors Spallone, V., Morganti, R., Siampli, M., Fedele, T., D'Amato, C., Cacciotti, L., Maiello, M. R.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.07.2009
Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Aims  The aim of the present study was to determine the diagnostic accuracy of the Neuropad sudomotor test for diabetic cardiovascular autonomic neuropathy (CAN) and diabetic polyneuropathy (DPN), the latter assessed using a multi‐level diagnostic approach. Methods  In 51 diabetic patients, CAN, symptoms and signs of DPN, vibration perception threshold (VPT), cold (CTT) and warm thermal perception thresholds (WTT) were measured. Neuropad response was determined as normal (complete colour change) or abnormal (absent or incomplete colour change). The time until the complete colour change (CCC time) was recorded. Results  CCC time showed significant correlations with all the neurological parameters, the strongest of which were with Valsalva ratio (ρ = −0.64, P < 0.0001), symptoms of DPN (ρ = 0.66, P < 0.0001), postural hypotension (ρ = 0.54, P = 0.0001) and CTT (ρ = −0.54, P = 0.0001). CCC time showed moderate diagnostic accuracy for both CAN and DPN: the areas under the receiver operating characteristic (ROC) curves were 0.71 and 0.76, respectively. The diagnostic characteristics of three cut‐off values of CCC time, identified by ROC analysis (i.e. 10, 15 and 18 min), were analysed. Compared with 10 min, the 15‐min cut‐off value provided better specificity (from 27% to 52% and from 31% to 62% for CAN and DPN, respectively) and a better likelihood ratio for negative result (from 0.67 to 0.34 and from 0.58 to 0.33) without lowering sensitivity (from 82% to 82% and from 85% to 80%). Conclusions  Neuropad is a reliable diagnostic tool for both CAN and DPN, albeit of only moderate accuracy. Extending the observation period to 15 min provides greater diagnostic usefulness.
Bibliography:ark:/67375/WNG-2SC90L9X-L
ArticleID:DME2760
istex:F8AAB946621767199D3AB8DC61E94F3A8636EA21
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0742-3071
1464-5491
DOI:10.1111/j.1464-5491.2009.02760.x